Paradoxical use of invasive cardiac procedures for patients with non-ST segment elevation myocardial infarction: An international perspective from the CRUSADE initiative and the Canadian ACS Registries I and II

Canadian Journal of Cardiology

Volumn 23, Issue 13, 2007, Pages 1073-1079

  Zia, Mohammad I ^a   Goodman, Shaun G ^a   Peterson, Eric D ^b   Mulgund, Jyotsna ^b   Chen, Anita Y ^b   Langer, Anatoly ^a   Tan, Mary ^a   Ohman, E Magnus ^c   Gibler, W Brian ^d   Pollack, Charles V ^e   Roe, Matthew T ^b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Acute coronary syndromes; Guidelines

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CANADA; CARDIOVASCULAR PROCEDURES; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; HEART CATHETERIZATION; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; INVASIVE PROCEDURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PREDICTION; QUALITATIVE ANALYSIS; REGISTER; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK MANAGEMENT; RISK REDUCTION; UNITED STATES; UNSTABLE ANGINA PECTORIS; ACUTE CORONARY SYNDROME; COMPARATIVE STUDY; ELECTROCARDIOGRAPHY; EMERGENCY HEALTH SERVICE; INTERNATIONAL COOPERATION; MIDDLE AGED; RISK FACTOR; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; UTILIZATION REVIEW;

ACUTE CORONARY SYNDROME; AGED; ANGINA, UNSTABLE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CANADA; ELECTROCARDIOGRAPHY; FEMALE; GUIDELINE ADHERENCE; HEART CATHETERIZATION; HUMANS; INTERNATIONALITY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PRACTICE GUIDELINES AS TOPIC; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TRIAGE; UNITED STATES;

EID: 38449113321     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0828-282X(07)70876-0     Document Type: Article

References (34)

1. Kochanek KD, Smith BL. Deaths: Preliminary data for 2002. Natl Vital Stat Rep 2004;52:1-47.
2. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators. Lancet 1999;354:708-15.
3. Cannon CP, Weintraub WS, Demopoulos LA, et at; TACTICS (Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy)-Thrombolysis in Myocardial Infarction 18 Investigators. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001;344:1879-87.
4. Fox KA, Poole-Wilson PA, Henderson RA, et al; Randomized Intervention Trial of unstable Angina Investigators. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: The British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina. Lancet 2002;360:743-51.
5. Wallentin L, Lagerqvist B, Husted S, Kontny F, Stähle E, Swahn E. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: The FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease. Lancet 2000;356:9-16.
6. Allen LA, O'Donnell CJ, Giugliano RP, Camargo CA Jr, Lloyd-Jones DM. Care concordant with guidelines predicts decreased long-term mortality in patients with unstable angina pectoris and non, ST-elevation myocardial infarction. Am J Cardiol 2004;93:1218-22.
7. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: Executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina). Circulation 2000;702:1193-209. (Erratum in 2000;102:1739).
8. Braunwald E, Antman EM, Beasley JW, et al; American College of Cardiology; American Heart Association. Committee on the Management of Patients With Unstable Angina. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction - summary article: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 2002;40:1366-74.
9. Fitchett D, Goodman S, Langer A. New advances in the management of acute coronary syndromes: 1. Matching treatment to risk. CMAJ 2001;164:1309-16.
10. Fitchett D, Goodman SG, Gupta M, Langer A. Preventing thrombosis: Update of first-line therapy in the management of non-ST segment elevation acute coronary syndromes. Can J Cardiol 2002;18:1179-90.
11. O'Neill BJ, Brophy JM, Simpson CS, et al; Canadian Cardiovascular Society Access to Care Working Group. Treating the right patient at the right time: Access to care in non-ST segment elevation acute coronary syndromes. Can J Cardiol 2005;21:1149-55.
12. Shamiss Y, Khaykin Y, Papastergiou J, et al. Risk stratification, management and outcomes of patients with non-ST elevation acute coronary syndrome: A Canadian teaching hospital perspective. Can J Cardiol 2003;19:1033-9.
13. Bhatt DL, Roe MT Peterson ED, et al; CRUSADE Investigators. Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: Results from the CRUSADE Quality Improvement Initiative. JAMA 2004;292:2096-104.
14. Rouleau JL, Moyé LA, Pfeffer MA, et al. A comparison of management patterns after acute myocardial infarction in Canada and the United States. The SAVE investigators. N Engl J Med 1993;328:779-84.
15. Mark DB, Naylor CD, Hlatky MA, et al. Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States. N Engl J Med 1994;331:1130-5.
16. Tu JV, Pashos CL, Naylor CD, et al. Use of cardiac procedures and outcomes in elderly patients with myocardial infarction in the United States and Canada. N Engl J Med 1997;336:1500-5. (Erratum in 1997;337:139).
17. Yusuf S, Flather M, Pogue J, et al. Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation. OASIS (Organisation to Assess Strategies for Ischaemic Syndromes) Registry Investigators. Lancet 1998;352:507-14,
18. Pilote L, Racine N, Hlatky MA. Differences in the treatment of myocardial infarction in the United States and Canada. A comparison of two university hospitals. Arch Intern Med 1994;154:1090-6.
19. Fu Y, Chang WC, Mark D, et al. Canadian-American differences in the management of acute coronary syndromes in the GUSTO IIb trial: One-year follow-up of patients without ST-segment elevation. Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) II Investigators. Circulation 2000;102:1375-81.
20. Batchelor WB, Peterson ED, Mark DB, et al. A comparison of U.S. and Canadian cardiac catheterization practices in detecting severe coronary artery disease after myocardial infarction: Efficiency, yield and long-term implications. J Am Coll Cardiol 1999;34:12-9.
21. Batchelor WB, Mark DB, Knight JD, et al. Development and validation of a simple model to predict severe coronary artery disease after myocardial infarction: Potential impact on cardiac catheterization use in the United States and Canada. Am Heart J 2003;145:349-55.
22. Yan AT, Yan RT Tan M, et al; Canadian Acute Coronary Syndromes (ACS) Registry Investigators. Troponin is more useful than creatine kinase in predicting one-year mortality among acute coronary syndrome patients. Eur Heart J 2004;25:2006-12.
23. Hoekstra JW, Pollack CV Jr, Roe MT et al. Improving the care of patients with non-ST-elevation acute coronary syndromes in the emergency department: The CRUSADE initiative. Acad Emerg Med 2002;9:1146-55.
24. Boersma E, Pieper KS, Steyerberg EW, et al. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. Circulation 2000;101:2557-67.
25. Liang K-Y, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22.
26. Steg PG, Dabbous OH, Feldman LJ, et al; Global Registry of Acute Coronary Events Investigators. Determinants and prognostic impact of heart failure complicating acute coronary syndromes: Observations from the Global Registry of Acute Coronary Events (GRACE). Circulation 2004;109:494-9.
27. Malmberg K, Yusuf S, Gerstein HC, et al. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: Results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation 2000;102:1014-9.
28. Masoudi FA, Plomondon ME, Magid DJ, Sales A, Rumsfeld JS. Renal insufficiency and mortality from acute coronary syndromes. Am Heart J 2004;147:623-9.
29. Bach RG, Cannon CP, Weintraub WS, et al. The effect of routine, early invasive management on outcome for elderly patients with non-ST,seginent elevation acute coronary syndromes. Ann Intern Med 2004;141:186-95.
30. Keeley EC, Kadakia R, Soman S, Borzak S, McCullough PA. Analysis of long-term survival after revascularization in patients with chronic kidney disease presenting with acute coronary syndromes. Am J Cardiol 2003;92:509-14.
31. Januzzi JL, Cannon CP, DiBattiste PM, Murphy S, Weintraub W, Braunwald E; TACTICS-TIMI 18 Investigators. Effects of renal insufficiency on early invasive management in patients with acute coronary syndromes (The TACTICS-TIMI 18 Trial). Am J Cardiol 2002;90:1246-9.
32. Alter DA, Naylor CD, Austin PC, Chan BT, Tu JV Geography and service supply do not explain socioeconomic gradients in angiography use after acute myocardial infarction. CMAJ 2003;168:261-4.
33. Yan AT, Jong P, Yan RT, et al; Canadian Acute Coronary Syndromes registry investigators. Clinical trial-derived risk model may not generalize to real-world patients with acute coronary syndrome. Am Heart J 2004;148:1020-7.
34. Mukherjee D, Fang J, Chetcuti S, Moscucci M, Kline-Rogers E, Eagle KA. Impact of combination evidence-based medical therapy on mortality in patients with acute coronary syndromes. Circulation 2004;109:745-9.